Overview

Neuropeptides in the Humane Intra- og Extracerebral Circulation.

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.
Phase:
N/A
Details
Lead Sponsor:
Danish Headache Center
Collaborators:
Bispebjerg Hospital
Glostrup University Hospital, Copenhagen
Treatments:
Sumatriptan